The U.S. Pharmacopeia (USP) is currently accepting public comments to their recently proposed chapter that would make it easier for U.S. biomedical companies to use synthetic alternatives to test for contamination in vaccines and medical devices, instead of a product derived from the blood of horseshoe crabs, known as LAL.